Tumor Necrosis Factor::Receptors
TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapy.
... associated factor 1 and complement component 5, it is currently not possible to assure which of these two genes at ...receptor-associated factor 1 (TRAF1), is a member of the TNF receptor (TNFR) associated ...
10
Structured intermittent interruption of chronic HIV infection treatment with highly active antiretroviral therapy: Effects on leptin and TNF-alpha.
... and tumor necrosis factor and its soluble receptors I and II were ...soluble receptors of tu- mor necrosis factor (TNFRI, 104 ...
8
Obesidad e inflamación
... 16. Nophar Y, Kemper O, Brakebusch C, Engelmann H, Zwang R, Adreka D, et al. Soluble forms of tumor necrosis factors (TNF- Rs). The cDNA for the type 1 TNF-R, cloned using amino acid sequence data of its ...
6
Antibody profiles in patients treated with tumor necrosis factor-alpha antagonists: new findings
... TNF-α receptors, which may partially explain the absence of organ-specific autoantibodies associated with autoimmune vasculitis, hepatitis, or endocrine ...
144
Adherence to the Mediterranean Diet and Inflammatory Markers
... leptin, tumor necrosis factor alpha (TNF- α ), plasminogen activator inhibitor 1 (PAI-1) and high-sensitivity C-reactive protein (hs-CRP) in adults, but not in young ...
13
Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.
... Treatment with alemtuzumab was well tolerated, with only 5 patients developing headache, low-grade fever, and/or chills after the first dose. None of the pa- tients developed injection-site skin reactions. Transient ...
6
Factor de necrosis tumoral: actividad biolgica en neumopatas intersticiales
... la necrosis tumoral en ratones tratados con lipopoli- sacárido, el factor de necrosis tumoral se sabe in- volucrado en la respuesta a una gran cantidad de estímulos, condicionando generalmente un ...
7
New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans
... To evaluate the production of intracellular interferon-gamma (IFN-γ) by T cells, PBMCs were incubated in the presence or absence of 10 nM leptin for 19 hr at 37°C and re-stimulated for 4 hr at 37°C with 25 ng/mL phorbol ...
11
Aspectos ms relevantes del sndrome peridico asociado al receptor del factor de necrosis tumoral
... provocados de inflamación, la cual podría ser sistémica u ocurrir en nichos localizados del organismo. Dentro de estos se encuentran los síndromes hereditarios de fiebre periódica, caracterizados por ataques cortos y ...
16
Estudi de la rellevància dels membres anti-apoptòtics de la família de Bcl-2 en la resistència a la mort induïda per la via extrínseca a través dels lligands de mort
... Resultats Capítol 3 141 Tal i com s’observa a la Figura R15, les cèl·lules U87MG són resistents a la mort induïda per TNFα, CH11 o TRAIL. Per tal de descartar si la resistència mostrada per aquestes cèl·lules no era ...
275
Vol. 89, Núm. 3 (2018)
... Several processes are involved in the association between obesity and inflammation, including adi- pocyte hypertrophy and hyperplasia, macrophage recruitment, increased hypoxia, increased oxidative stress, and increased ...
6
Pleiotrophin regulates microglia mediated neuroinflammation / R Fernández Calle [et al ]
... of tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β), interleukin 6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), interleukin 4 (IL-4), and interleukin 10 (IL-10) were measured by X-Map ...
10
Tumor Necrosis Factor α Regulates Glucocorticoid Synthesis in the Adrenal Glands of Trypanosoma cruzi Acutely Infected Mice The Role of TNF R1
... Adrenal gland nuclear fractions were obtained by homogeni- zation of frozen tissues in lysis buffer (PBS, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM phenylmethylsul- fonyl fluoride and 10 g/ml leupeptin). ...
13
Tumor intrabdominal desmoplásico de células pequeñas redondas. Reporte de un caso
... cell tumor is a rare mesenchymal ...the tumor located in the parietal peritoneum was made, which was guided by laparoscopy, where a dermoplastic small round cell intra-abdominal tumor is ...extensive ...
9
TítuloEvaluation of 12 GWAS drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors A potential SNP association with response to etanercept
... Another factor likely contributing to the lack of reproducibility is the heterogeneity of the outcomes [36,40]. This issue has been poorly studied, but there are differences in heritability between the components ...
14
Tristetraprolina Proteína reguladora del TNF-α de importancia patogénica en artritis reumatoide
... El factor de necrosis tumoral α (TNF- α ) es un mediador de la respuesta inflamatoria aguda y crónica en varias enfermedades (1). Además, ha sido bien conocido su papel en el choque séptico (2-4) y en la ...
7
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists
... 23. Solau-Gervais E, Laxenaire N, Cortet B, Dubucquoi S, Duquesnoy B, Flipo RM: Lack of efficacy of a third tumour necrosis factor alpha antagonist after failure of a soluble receptor and a monoclonal ...
7
Eicosanoids and tumor necrosis factor alpha in the kidney
... Hypertension is a major independent risk factor for heart attack, stroke, and end-stage renal disease. Complex genetic and environmental factors contribute to the pathogenesis of essential hypertension, and ...
6
Expresión de genes inmunorrelacionados y de estrés térmico en abulón rojo, Haliotis rufescens, sintomático al síndrome de deshidrataciónExpression of immune related genes and heat shock in red abalone Haliotis rufescens asymptomatic to the withering syndrome
... Like Factor; AbTNF-α, Abalone Tumor Necrosis-alfa; MEP, Macrófagos Expressed Protein), antioxidant metabolism (Catalase; SeGPx, Selenium dependent glutathione-S- transferase; GSTisof1, ...
111
Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis.
... The multivariate regression model showed that the predic- tors of drug survival in anti-TNF therapy for RA were: being rhematoid-factor negative; being 60 years of age or older; and not having had previous ...
9